Figure 3.
Impact of hematologic responses on survival in stage IIIb AL amyloidosis. Kaplan-Meier survival curves according to categorical hematologic responses at 1-month landmark: VGPR, 47 months; PR, 25 months; NR, 5 months (A-B), 3-month landmark: CR, 55 months; VGPR, 37 months; PR, 15 months; NR, 8 months (C), and best response: CR, 85 months; VGPR, 22 months; PR, 11 months; NR, 4 months (D).